![LGALS3BP rabbit monoclonal antibody package:50 μl Aug 2011] Swissprot No P10109](https://cdn.shopify.com/s/files/1/0521/5312/2997/files/P290835-WB-1-P_3e34dee2-e2a8-4387-a0a2-070789f5cffe.jpg?v=1739293823)
Pay in 4 interest-free payments of $28.25 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Aug 2011] Swissprot No P10109 Gene Accession 2230 WB Predicted band size 19 kDa WB Positive control WB Recommended dilution 500-2000 IHC predicted cell location Predicted cell location: Cytoplasm IHC positive control Positive control: Human colon cancer IHC Recommed dilution Recommended dilution: 50-100 Storage
5 g/L glucose) supports energy-demanding cells with elevated metabolic activity
appearance
The vials are made of borosilicate glass and are available in amber color
Immunohistochemical analysis of paraffin-embedded Human colon cancer tissue using P290579(GLA Antibody) at dilution 1/50
LGALS3BP rabbit monoclonal antibody package:50 μl Aug 2011] Swissprot No P10109Specification Full name LGALS3BP rabbit monoclonal antibody Alternative names 50 l 100 l Reactivity rabbit monoclonal Applications WB Host Rabbit Clone type rabbit monoclonal Target Background The galectins are a family of beta galactoside binding proteins implicated in modulating cell cell and cell matrix interactions. LGALS3BP has been found elevated in the serum of patients with cancer and in those infected by the human immunodeficiency virus